Understanding host immune responses to pneumococcal proteins in the upper respiratory tract to develop serotype-independent pneumococcal vaccines

References

• Ciapponi A, Elorriaga N, Rojas JI, et al. Epidemiology of pediatric pneumococcal meningitis and bacteremia in Latin America and the caribbean: A systematic review and meta-analysis. Pediatr Infect Dis J. 2014;33(9):971–978.
   PubMed Web of Science ®Google Scholar
• O’Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893–902.
   PubMed Web of Science ®Google Scholar
• Mook-Kanamori BB, Geldhoff M, van der Poll T, et al. Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev. 2011;24(3):557–591.
   PubMed Web of Science ®Google Scholar
• Aligholi M, Emaneini M, Jabalameli F, et al. Antibiotic susceptibility pattern of gram-positive cocci cultured from patients in three university hospitals in Tehran, Iran during 2001–2005. Acta Med. Iran. 2009;47:329–334.
   Google Scholar
• Bentley SD, Aanensen DM, Mavroidi A, et al. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet. 2006;2(3):262–269.
   Web of Science ®Google Scholar
• Hausdorff WP, Bryant J, Paradiso PR, et al. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 2000;30(1):100–121.
   PubMed Web of Science ®Google Scholar
• Lijek RS, Weiser JN. Co-infection subverts mucosal immunity in the upper respiratory tract. Curr Opin Immunol. 2012;24(4):417–423.
   PubMed Web of Science ®Google Scholar
• Simell B, Auranen K, Käyhty H, et al. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines. 2012;11(7):841–855.
   PubMed Web of Science ®Google Scholar
• Poolman JT, Peeters CC, Van Den Dobbelsteen GP. The history of pneumococcal conjugate vaccine development: dose selection. Expert Rev Vaccines. 2013;12(12):1379–1394.
   PubMed Web of Science ®Google Scholar
• Mitsi E, Roche AM, Reiné J, et al. Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage. Mucosal Immunol. 2017;10(2):385–394.
   PubMed Web of Science ®Google Scholar
• McFetridge R, Meulen AS, Folkerth SD, et al. Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults. Vaccine. 2015;33(24):2793–2799.
   PubMed Web of Science ®Google Scholar
• Sobanjo-ter Meulen A, Vesikari T, Malacaman EA, et al. Safety, tolerability and immunogenicity of 15-valent pneumococcal conjugate vaccine in toddlers previously vaccinated with 7-valent pneumococcal conjugate vaccine. J. Pediatr. Infect. Dis. 2015;34(2):186–194.
   PubMed Web of Science ®Google Scholar
• Tai SS. Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies. Crit. Rev. Microbiol. 2006;32(3):139–153.
   PubMed Web of Science ®Google Scholar
• Lagousi T, Basdeki P, Routsias J, et al. Novel protein-based pneumococcal vaccines: assessing the use of distinct protein fragments instead of full-length proteins as vaccine antigens. Vaccines (Basel). 2019;7(1):9.
   PubMed Web of Science ®Google Scholar
• Bruyn GAW, Zegers BJM, van Furth R. Mechanisms of host defense against infection with Streptococcus pneumoniae. Clin Infect Dis. 1992;14(1):251–262.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Bernatoniene J, Bagrade L, et al. Regulation of production of mucosal antibody to pneumococcal protein antigens by T-cell-derived gamma interferon and interleukin-10 in children. Infect Immun. 2006;74(8):4735–4743.
   PubMed Web of Science ®Google Scholar
• Mureithi MW, Finn A, Ota MO, et al. T cell memory response to pneumococcal protein antigens in an area of high pneumococcal carriage and disease. J Infect Dis. 2009;200(5):783–793.
   PubMed Web of Science ®Google Scholar
• McAleer JP, Kolls JK. Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense. Immunol Rev. 2014;260(1):129–144.
   PubMed Web of Science ®Google Scholar
• Darrieux M, Moreno AT, Ferreira DM, et al. Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades. J Med Microbiol. 2008;57:273–278.
   PubMed Web of Science ®Google Scholar
• Mccool TL, Cate TR, Moy G, et al. The immune response to pneumococcal proteins during experimental human carriage. J Exp Med. 2002;195(3):359–365.
   Google Scholar
• Ferreira DM, Neill DR, Bangert M, et al. Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am J Respir Crit Care Med. 2013;187(8):855–864.
   PubMed Web of Science ®Google Scholar
• Wright AKA, Bangert M, Gritzfeld JF, et al. Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung. PLoS Pathog. 2013;9:3.
   Web of Science ®Google Scholar
• Gilks CF, Ojoo SA, Ojoo JC, et al. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya. Lancet. 1996;347(9003):718–723.
   PubMed Web of Science ®Google Scholar
• Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Nat Rev Microbiol. 2018;16(6):355–367.
   PubMed Web of Science ®Google Scholar
• Syrjänen RK, Kilpi TM, Kaijalainen TH, Herva EE, Takala AK. Nasopharyngeal Carriage of Streptococcus pneumoniae in Finnish Children Younger Than 2 Years Old. J Infect Dis. 2001;184:451-9.
   Google Scholar
• Dunkelberger JR, Song W-C. Complement and its role in innate and adaptive immune responses. Cell Res. 2010;20:34–50.
   PubMed Web of Science ®Google Scholar
• Roche AM, Richard AL, Rahkola JT, et al. Antibody blocks acquisition of bacterial colonization through agglutination. Mucosal Immunol. 2015;8(1):176–185.
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Nistico L, Sambanthamoorthy K, et al. Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in streptococcus pneumoniae clinical isolates. BMC Microbiol. 2008;8:173.
   PubMed Web of Science ®Google Scholar
• Kim JO, Weiser JN. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of streptococcus pneumoniae. J Infect Dis. 1998;177(2):368–377.
   PubMed Web of Science ®Google Scholar
• Habets MN, Van Selm S, Van Der Gaast De Jongh CE, et al. A novel flow cytometry-based assay for the quantification of antibody-dependent pneumococcal agglutination. PLoS One. 2017;12:3.
   Web of Science ®Google Scholar
• Khan MN, Sharma SK, Filkins LM, et al. PcpA of streptococcus pneumoniae mediates adherence to nasopharyngeal and lung epithelial cells and elicits functional antibodies in humans. Microbes Infect. 2012;14(12):1102–1110.
   PubMed Web of Science ®Google Scholar
• Khan MN, Pichichero ME. Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans. Vaccine. 2012;30(18):2900–2907.
   PubMed Web of Science ®Google Scholar
• Papastamatiou T, Routsias JG, Koutsoni O, et al. Evaluation of protective efficacy of selected immunodominant B-cell epitopes within virulent surface proteins of streptococcus pneumoniae. Infect Immun. 2018;86:3.
   Web of Science ®Google Scholar
• Weiser JN, Austrian R, Sreenivasan PK, et al. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun. 1994;62(6):2582–2589.
   PubMed Web of Science ®Google Scholar
• Alper CA, Johnson AM, Birtch AG, et al. Human C’3: evidence for the liver as the primary site of synthesis. Science. 1969;163(3864):286–288.
   PubMed Web of Science ®Google Scholar
• Lubbers R, van Essen MF, van Kooten C, et al. Production of complement components by cells of the immune system. Clin Exp Immunol. 2017;188(2):183–194.
   PubMed Web of Science ®Google Scholar
• Glennie S, Gritzfeld JF, Pennington SH, et al. Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage. Mucosal Immunol. 2016;9:56–67.
   PubMed Web of Science ®Google Scholar
• Hammerschmidt S, Agarwal V, Kunert A, et al. The host immune regulator factor H interacts via two contact sites with the PspC protein of streptococcus pneumoniae and mediates adhesion to host epithelial cells. J Immunol. 2007;178(9):5848–5858.
   PubMed Web of Science ®Google Scholar
• Bogaert D, De Groot R, Hermans PWM. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4(3):144–154.
   PubMed Web of Science ®Google Scholar
• Rajam G, Anderton JM, Carlone GM, et al. Pneumococcal surface adhesin A (PsaA): A review. Crit. Rev. Microbiol. 2008;34(3–4):131–142.
   PubMed Web of Science ®Google Scholar
• Rosenow C, Ryan P, Weiser JN, et al. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of streptococcus pneumoniae. Mol Microbiol. 1997;25(5):819–829.
   PubMed Web of Science ®Google Scholar
• Pracht D, Elm C, Gerber J, et al. PavA of Streptococcus pneumoniae modulates adherence, invasion, and meningeal inflammation. Infect Immun. 2005;73(5):2680–2689.
   PubMed Web of Science ®Google Scholar
• Rose L, Shivshankar P, Hinojosa E, et al. Antibodies against PsrP, a novel streptococcus pneumoniae adhesin, block adhesion and protect mice against pneumococcal challenge. J Infect Dis. 2008;198(3):375–383.
   PubMed Web of Science ®Google Scholar
• Rosenow C, Ryan P, Weiser JN, et al. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of streptococcus pneumoniae. Mol Microbiol. 1997;25(5):819–829.
   PubMed Web of Science ®Google Scholar
• Romero-Steiner S, Pilishvili T, Sampson JS, et al. Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies. Clin Diagn Lab Immunol. 2003;10(2):246–251.
   PubMedGoogle Scholar
• Romero-Steiner S, Caba J, Rajam G, et al. Adherence of recombinant pneumococcal surface adhesin A (rPsaA)-coated particles to human nasopharyngeal epithelial cells for the evaluation of anti-PsaA functional antibodies. Vaccine. 2006;24:3224–3231.
   PubMed Web of Science ®Google Scholar
• Rajam G, Phillips DJ, White E, et al. A functional epitope of the pneumococcal surface adhesin A activates nasopharyngeal cells and increases bacterial internalization. Microb Pathog. 2008;44(3):186–196.
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Kaur R, Casey JR, et al. Antibody response to streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children. Hum Vaccin Immunother. 2012;8(6):799–805.
   PubMed Web of Science ®Google Scholar
• Kaur R, Surendran N, Ochs M, et al. Human antibodies to PhtD, PcpA, and ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae. Infect Immun. 2014;82(12):5069–5075.
   PubMed Web of Science ®Google Scholar
• Johnston JW, Briles DE, Myers LE, et al. Mn2+-dependent regulation of multiple genes in streptococcus pneumoniae through PsaR and the resultant impact on virulence. Infect Immun. 2006;74(2):1171–1180.
   PubMed Web of Science ®Google Scholar
• Kaur R, Casey JR, Pichichero ME. Serum antibody response to five streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children. Pediatr Infect. Dis J. 2011;30(8):645–650.
   PubMed Web of Science ®Google Scholar
• Shak JR, Ludewick HP, Howery KE, et al. Novel role for the streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms. MBio. 2013;4:5.
   Web of Science ®Google Scholar
• Rubins JB, Paddock AH, Charboneau D, et al. Pneumolysin in pneumococcal adherence and colonization. Microb Pathog. 1998;25(6):337–342.
   PubMed Web of Science ®Google Scholar
• Neill DR, Coward WR, Gritzfeld JF, et al. Density and duration of pneumococcal carriage is maintained by transforming growth factor β1 and T regulatory cells. Am J Respir Crit Care Med. 2014;189(10):1250–1259.
   PubMed Web of Science ®Google Scholar
• Honsa ES, Johnson MDL, Rosch JW. The roles of transition metals in the physiology and pathogenesis of streptococcus pneumoniae. Front Cell Infect Microbiol. 2013;3:92.
   PubMed Web of Science ®Google Scholar
• Ogunniyi AD, Grabowicz M, Mahdi LK, et al. Pneumococcal histidine triad proteins are regulated by the Zn 2+ ‐dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H. Faseb J. 2009;23:731–738.
   PubMed Web of Science ®Google Scholar
• Shafeeq S, Kuipers OP, Kloosterman TG. The role of zinc in the interplay between pathogenic streptococci and their hosts. Mol Microbiol. 2013;88(6):1047–1057.
   PubMed Web of Science ®Google Scholar
• Riboldi-Tunnicliffe A, Isaacs NW, Mitchell TJ. 1.2 Å crystal structure of the S. pneumoniae PhtA histidine triad domain a novel zinc binding fold. FEBS Lett. 2005;579(24):5353–5360.
   PubMed Web of Science ®Google Scholar
• Lagousi T, Routsias J, Piperi C, et al. Discovery of immunodominant B cell epitopes within surface pneumococcal virulence proteins in pediatric patients with invasive pneumococcal disease. J Biol Chem. 2015;290(46):27500–27510.
   PubMed Web of Science ®Google Scholar
• Godfroid F, Hermand P, Verlant V, et al. Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens. Infect Immun. 2011;79:238–245.
   PubMed Web of Science ®Google Scholar
• Rioux S, Neyt C, Di Paolo E, et al. Transcriptional regulation, occurrence and putative role of the Pht family of streptococcus pneumoniae. Microbiology. 2011;157:335–348.
   Web of Science ®Google Scholar
• Kallio A, Sepponen K, Hermand P, et al. Role of Pht proteins in attachment of streptococcus pneumoniae to respiratory epithelial cells. Infect Immun. 2014;82:1683–1691.
   PubMed Web of Science ®Google Scholar
• Routsias JG, Kosmopoulou A, Makri A, et al. Zinc ion dependent B-cell epitope, associated with primary sjogren’s syndrome, resides within the putative zinc finger domain of Ro60kD autoantigen: physical and immunologic properties. J Med Chem. 2004;47(17):4327–4334.
   Google Scholar
• Briles DE, Ades E, Paton JC, et al. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of streptococcus pneumoniae. Infect Immun. 2000;68:796–800.
   PubMed Web of Science ®Google Scholar
• Voß F, Kohler TP, Meyer T, et al. Intranasal vaccination with lipoproteins confers protection against pneumococcal colonisation. Front Immunol. 2018;9:2405.
   PubMed Web of Science ®Google Scholar
• McCool TL, Weiser JN. Limited role of antibody in clearance of streptococcus pneumoniae in a murine model of colonization. Infect Immun. 2004;72(10):5807–5813.
   PubMed Web of Science ®Google Scholar
• Trzciński K, Thompson C, Malley R, et al. Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model. Infect Immun. 2005;73(10):7043–7046.
   PubMed Web of Science ®Google Scholar
• Converso TR, Goulart C, Darrieux M, et al. A protein chimera including PspA in fusion with PotD is protective against invasive pneumococcal infection and reduces nasopharyngeal colonization in mice. Vaccine. 2017;35(38):5140–5147.
   PubMed Web of Science ®Google Scholar
• Whaley MJ, Sampson JS, Johnson SE, et al. Concomitant administration of recombinant PsaA and PCV7 reduces streptococcus pneumoniae serotype 19A colonization in a murine model. Vaccine. 2010;28(18):3071–3075.
   PubMed Web of Science ®Google Scholar
• Dhoubhadel BG, Yasunami M, Nguyen HAT, et al. Bacterial load of pneumococcal serotypes correlates with their prevalence and multiple serotypes is associated with acute respiratory infections among children less than 5 years of age. PLoS One. 2014;9:10.
   Web of Science ®Google Scholar
• Brotons P, Bassat Q, Lanaspa M, et al. Nasopharyngeal bacterial load as a marker for rapid and easy diagnosis of invasive pneumococcal disease in children from Mozambique. PLoS One. 2017;12:9.
   Web of Science ®Google Scholar
• Pichichero ME. Ten-year study of the stringently defined otitis-prone child in Rochester, NY. Pediatr Infect Dis J. 2016;35(9):1033–1039.
   PubMed Web of Science ®Google Scholar
• Azarian T, Grant LR, Georgieva M, et al. Association of pneumococcal protein antigen serology with age and antigenic profile of colonizing isolates. J Infect Dis. 2017;215(5):713–722.
   PubMed Web of Science ®Google Scholar
• Mendy AL, Agbla SC, Odutola AA, et al. Kinetics of antibodies against pneumococcal proteins and their relationship to nasopharyngeal carriage in the first two months of life. PLoS One. 2017;12:10.
   Web of Science ®Google Scholar
• Prevaes SMPJ, van Wamel WJB, de Vogel CP, et al. Nasopharyngeal colonization elicits antibody responses to staphylococcal and pneumococcal proteins that are not associated with a reduced risk of subsequent carriage. Infect Immun. 2012;80::2186–2193.
   PubMed Web of Science ®Google Scholar
• Pennington SH, Pojar S, Mitsi E, et al. Polysaccharide-specific memory B cells predict protection against experimental human pneumococcal carriage. Am J Respir Crit Care Med. 2016;194:1523–1531.
   PubMed Web of Science ®Google Scholar
• Odutola A, Ota MOC, Antonio M, et al. Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study. Vaccine. 2017;35:2531–2542.
   PubMed Web of Science ®Google Scholar
• Xu Q, Casey JR, Almudevar A, et al. Correlation of higher antibody levels to pneumococcal proteins with protection from pneumococcal acute otitis media but not protection from nasopharyngeal colonization in young children. Clin Microbiol Infect. 2017;23:7.
   Web of Science ®Google Scholar
• Andrews NJ, Waight PA, Burbidge P, et al. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis. 2014;14::839–846.
   PubMed Web of Science ®Google Scholar
• Lu YJ, Gross J, Bogaert D, et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 2008;4:9.
   Web of Science ®Google Scholar
• Zhang Z, Clarke TB, Weiser JN. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest. 2009;119:1899.
   PubMed Web of Science ®Google Scholar
• Davis KM, Nakamura S, Weiser JN. Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J Clin Invest. 2011;121:3666–3676.
   PubMed Web of Science ®Google Scholar
• Ronchetti R, Villa MP, Martella S, et al. Nasal cellularity in 183 unselected schoolchildren aged 9 to 11 years. Pediatrics. 2002;110:1137-42.
   Web of Science ®Google Scholar
• Jochems SP, Piddock K, Rylance J, et al. Novel analysis of immune cells from nasal microbiopsy demonstrates reliable, reproducible data for immune populations, and superior cytokine detection compared to nasal wash. PLoS One. 2017;12:e0169805.
   Web of Science ®Google Scholar
• Van Rossum AMC, Lysenko ES, Weiser JN. Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model. Infect Immun. 2005;73:7718–7726.
   PubMed Web of Science ®Google Scholar
• Gwaltney JM, Sande MA, Austrian R, et al. Spread of streptococcus pneumoniae in families. II. relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J Infect Dis. 1975;132:1.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Arnaoutakis K, Murdoch C, et al. Mucosal immune responses to capsular pneumococcal polysaccharides in immunized preschool children and controls with similar nasal pneumococcal colonization rates. Pediatr Infect Dis J. 2004;23(4):307–313.
   PubMed Web of Science ®Google Scholar
• Simell B, Kilpi TM, Käyhty H. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children. J Infect Dis. 2002;186(8):1106–1114.
   PubMed Web of Science ®Google Scholar
• Malley R, Srivastava A, Lipsitch M, et al. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun. 2006;74:2187–2195.
   PubMed Web of Science ®Google Scholar
• Basset A, Thompson CM, Hollingshead SK, et al. Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins. Infect Immun. 2007;75:5460–5464.
   PubMed Web of Science ®Google Scholar
• Malley R, Trzcinski K, Srivastava A, et al. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci. 2005;102(13):4848–4853.
   PubMed Web of Science ®Google Scholar
• Moens L, Hermand P, Wellens T, et al. Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization. Hum.Vaccin Immunother. 2018;14::1234–1242.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Leong SC, McNamara PS, et al. Characterisation of regulatory t cells in nasal associated lymphoid tissue in children: relationships with pneumococcal colonization. PLoS Pathog. 2011;7:8.
   Web of Science ®Google Scholar
• Pido-Lopez J, Kwok WW, Mitchell TJ, et al. Acquisition of pneumococci specific effector and regulatory Cd4 + T cells localising within human upper respiratory-tract mucosal lymphoid tissue. PLoS Pathog. 2011;7:12.
   Web of Science ®Google Scholar
• Mubarak A, Ahmed MS, Upile N, et al. A dynamic relationship between mucosal T helper type 17 and regulatory T-cell populations in nasopharynx evolves with age and associates with the clearance of pneumococcal carriage in humans. Clin Microbiol Infect. 2016;22:8.
   PubMed Web of Science ®Google Scholar
• Jiang XL, Zhang GL, Yang T, et al. Association of pneumococcal carriage and expression of Foxp3+ regulatory T cells and Th17 cells in the adenoids of children. Respiration. 2015;90:25–32.
   PubMed Web of Science ®Google Scholar
• Gray C, Ahmed MS, Mubarak A, et al. Activation of memory Th17 cells by domain 4 pneumolysin in human nasopharynx-associated lymphoid tissue and its association with pneumococcal carriage. Mucosal Immunol. 2014;7:705–717.
   PubMed Web of Science ®Google Scholar
• Vuononvirta J, Peltola V, Ilonen J, et al. The gene polymorphism of IL-17 G-152A is associated with increased colonization of streptococcus pneumoniae in young finnish children. Pediatr Infect Dis J. 2015;34:928–932.
   PubMed Web of Science ®Google Scholar
• Gross JE, Lu YJ, Forte S, et al. IL-22 predicts resistance to bacterial colonization in adults with chronic obstructive pulmonary disease. ISPPD7. Tel Aviv, Israel (2010)
   Google Scholar
• Lundgren A, Bhuiyan TR, Novak D, et al. Characterization of Th17 responses to streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country. Vaccine. 2012;30:3897–3907.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Bagrade L, Bernatoniene J, et al. Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children. J Infect Dis. 2007;195:1194–1202.
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Kaur R, Casey JR, et al. Antibody response to streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children. Hum Vaccines Immunother. 2012;8:799–805.
   PubMed Web of Science ®Google Scholar
• Goulart C, Rodriguez D, Kanno AI, et al. A combination of recombinant mycobacterium bovis BCG strains expressing pneumococcal proteins induces cellular and humoral immune responses and protects against pneumococcal colonization and sepsis. Clin Vaccine Immunol. 2017;24:e00133-17.
   Google Scholar
• Skoberne M, Ferreira DM, Hetherington S, et al. Pneumococcal protein vaccine GEN-004 reduces experimental human pneumococcal carriage in healthy adults. Int Symp Pneumococci Pneumococcal Dis. Glasgow, UK (2016)
   Google Scholar
• Mozdzanowska K, Zharikova D, Cudic M, et al. Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse. Virol J. 2007;4:118.
   PubMed Web of Science ®Google Scholar
• Debache K, Guionaud C, Alaeddine F, et al. Intraperitoneal and intranasal vaccination of mice with three distinct recombinant neospora caninum antigens results in differential effects with regard to protection against experimental challenge with neospora caninum tachyzoites. Parasitology. 2010;137:229–240.
   PubMed Web of Science ®Google Scholar
• Svanborg-Edén C, Svennerholm AM. Secretory immunoglobulin A and G antibodies prevent adhesion of escherichia coli to human urinary tract epithelial cells. Infect Immun. 1978;22:790–797.
   PubMed Web of Science ®Google Scholar
• Johnson S, Sypura WD, Gerding DN, et al. Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease. Infect Immun. 1995;63:3166–3173.
   PubMed Web of Science ®Google Scholar
• Mazanec MB, Kaetzel CS, Lamm ME, et al. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci. 1992;89:6901–6905.
   PubMed Web of Science ®Google Scholar
• Underdown BJ, Schiff JM. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu Rev Immunol. 1986;4:389–417.
   PubMed Web of Science ®Google Scholar
• Brewer JM, Conacher M, Hunter CA, et al. Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling. J Immunol. 1999;163:6448–6454.
   PubMed Web of Science ®Google Scholar
• Marqués JM, Rial A, Muñoz N, et al. Protection against streptococcus pneumoniae serotype 1 acute infection shows a signature of Th17- and IFN-γ-mediated immunity. Immunobiology. 2012;217:420–429.
   PubMed Web of Science ®Google Scholar
• Voß F, van Beek LF, Schwudke D, et al. Lipidation of pneumococcal antigens leads to improved immunogenicity and protection. Vaccines. 2020;8:310.
   Web of Science ®Google Scholar
• McDaniel LS, Swiatlo E. Should pneumococcal vaccines eliminate nasopharyngeal colonization? MBio. 2016;7::16–17.
   Web of Science ®Google Scholar
• Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis. 2000;31:578–585.
   PubMed Web of Science ®Google Scholar
• Haynes L, Eaton SM. The effect of age on the cognate function of CD4+ T cells. Immunol Rev. 2005;205:220–228.
   PubMed Web of Science ®Google Scholar
• Linton P-J, Li SP, Zhang Y, et al. Intrinsic versus environmental influences on T-cell responses in aging. Immunol Rev. 2005;205:207–219.
   PubMed Web of Science ®Google Scholar
• Jiang J, Bennett AJ, Fisher E, et al. Limited expansion of virus-specific CD8 T cells in the aged environment. Mech Ageing Dev. 2009;130:713–721.
   PubMed Web of Science ®Google Scholar
• Goronzy JJ, Hu B, Kim C, et al. Epigenetics of T cell aging. J Leukocyte Biol. 2018;104:691–699.
   PubMed Web of Science ®Google Scholar
• Marwaha AK, Leung NJ, McMurchy AN, et al. TH17 cells in autoimmunity and immunodeficiency: protective or pathogenic? Front Immunol. 2012;3:129.
   PubMed Web of Science ®Google Scholar
• Pichichero ME. Challenges in vaccination of neonates, infants and young children. Vaccine. 2014;32(31):3886–3894.
   PubMed Web of Science ®Google Scholar
• Grijalva CG, Griffin MR, Edwards KM, et al. The role of influenza and parainfluenza infections in nasopharyngeal pneumococcal acquisition among young children. Clin Infect Dis. 2014;58(10):1369–1376.
   PubMed Web of Science ®Google Scholar
• Morpeth SC, Munywoki P, Hammitt LL, et al. Impact of viral upper respiratory tract infection on the concentration of nasopharyngeal pneumococcal carriage among Kenyan children. Sci Rep. 2018;8:11030.
   Web of Science ®Google Scholar
• Lu YJ, Oliver E, Zhang F, et al. Screening for Th17-dependent pneumococcal vaccine antigens: comparison of murine and human cellular immune responses. Infect Immun. 2018;86:11.
   Web of Science ®Google Scholar
• Kuipers K, van Selm S, van Opzeeland F, et al. Genetic background impacts vaccine-induced reduction of pneumococcal colonization. Vaccine. 2017;35:5235–5241.
   PubMed Web of Science ®Google Scholar
• Pulendran B, Li S, Nakaya HI. Systems vaccinology. Immunity. 2010;33:516–529.
   PubMed Web of Science ®Google Scholar
• Hagan T, Nakaya HI, Subramaniam S, et al. Systems vaccinology: enabling rational vaccine design with systems biological approaches. Vaccine. 2015;33:5294–5301.
   PubMed Web of Science ®Google Scholar
• Khan MN, Pichichero ME. CD4+ T-cell memory and antibody responses directed against the pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice. Infect Immun. 2013;81(10):3781–3792.
   PubMed Web of Science ®Google Scholar
• Balachandran P, Brooks-Walter A, Virolainen-Julkunen A, et al. Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of streptococcus pneumoniae. Infect Immun. 2002;70(5):2526–2534.
   PubMed Web of Science ®Google Scholar